Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06857890

Safety, Tolerability, and Pharmacokinetic Profile of Grammidin With Anesthetic, a Metered Dose Topical Spray in Healthy Volunteers

An Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of the Drug Grammidin With Anesthetic, a Metered Dose Topical Spray Following Single Administration in Healthy Volunteers

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Valenta Pharm JSC · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study aims to evaluate the safety, tolerability, and pharmacokinetic profile of the Grammidin with anesthetic, a metered dose topical spray, compared to Grammidin with anesthetic neo, lozenges following single administration in healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGGrammidin with anesthetic neoGrammidin with anesthetic neo, lozenges, 1 lozenge to be taken once under fed conditions.
DRUGGrammidin with anesthetic, a metered dose topical sprayGrammidin with anesthetic, a metered dose topical spray, 4 sprays to be taken once under fed conditions

Timeline

Start date
2024-12-09
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-03-05
Last updated
2025-07-10

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT06857890. Inclusion in this directory is not an endorsement.